EAU 2006: SUNRISE* Study Backgrounder
Wednesday, 12 April 2006
* Solifenacin in the treatment of UrgeNcy symptoms of overactive bladder in a RISing dose, randomised, placebo controlled, double blind, Efficacy trial
read more
|
EAU 2006: A Critical Analysis Of New Drug Therapies
Friday, 07 April 2006
On Wednesday 5 April 2006 the European Association of Urology (EAU) held a welcome press address during its 21st Annual Congress. The EAU congress covers the whole spectrum of modern urology; over 11,500 people have registered so far.
read more
|
EAU 2006: Major New Study Confirms Solifenacin Effectively Treats Urgency - The Core Symptom In Overactive
Thursday, 13 April 2006
Paris, April 2006. New data presented today at the European Association of Urology Congress confirm that solifenacin (Vesicare®) provides fast, effective treatment of urgency, the symptom that drives all the other problems of overactive bladder syndrome (DAB), and causes the most bother to patients 1.
read more
|
Conference Coverage 
